GlassScriptPhysician profile
Laura M Hower
NPI 1699081661
$1,584.92
in general payments reported to CMS, 2019-2025
13 companies · $291 in 2025
The $291 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $282 · 2022: $219 · 2023: $459 · 2024: $334 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,085.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,084.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $575.47 | 2021-2025 | Floseal, Coseal, Preveleak |
| W. L. Gore & Associates, INC. | $182.39 | 2021-2025 | Gore Tag Thoracic Branch Endoprosthesis |
| Abiomed | $170.33 | 2024 | Impella |
| Atricure, INC. | $139.33 | 2022-2024 | |
| Getinge USA Sales, LLC | $123.82 | 2021 | |
| Depuy Synthes Sales INC. | $101.47 | 2024-2025 | Matrixrib, Na |
| Medtronic, INC. | $84.86 | 2025 | Penditure, Aquamantys(Tm), Sonicision |
| Bolton Medical INC | $63.75 | 2022-2023 | Treo Abdominal Stent-Graft System |
| Edwards Lifesciences Corporation | $43.02 | 2025 | Mitris Resilia Mitral Valve |
| Alexion Pharmaceuticals, INC. | $39.78 | 2022 | |
| Lemaitre Vascular, INC. | $33.51 | 2023 | Hydro Lemaitre Valvulotome, Cardiocel |
| Kls-Martin L.P. | $17.46 | 2022 | |
| Cvrx, INC. | $9.73 | 2023 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Hower listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.